Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Interventional, Double-Blinded, 2-Arm Study to Investigate the Efficacy of Orally Administered Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir in Non-hospitalized Adult Participants Suffering from Post-COVID

NCT05823896 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT05823896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05823896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Interventional, Double-Blinded, 2-Arm Study to Investigate the Efficacy of Orally Administered Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir in Non-hospitalized Adult Participants Suffering from Post-COVID
Lead sponsor
Karolinska Institutet
Phase
Phase 2
Overall status
Completed
Start date
May 1, 2023
Completion date
November 28, 2024
Enrollment
219 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, long covid, long covid19, post covid-19 condition, post covid-19 condition, unspecified, post-covid syndrome, post-covid-19 syndrome, postinfectious disorder, postinfectious inflammation, pots - postural orthostatic tachycardia syndrome